Medindia

X

Cadila Gets Tentative USFDA Nod For Pravastatin Sodium Tablets

by Medindia Content Team on  June 15, 2006 at 6:56 PM Drug News   - G J E 4
Cadila Gets Tentative USFDA Nod For Pravastatin Sodium Tablets
Cadila Healthcare Ltd has received tentative approval from the USFDA to market Pravastatin Sodium Tablets in the US market.

The tentative approval was given for strengths of 10 mg, 20 mg, 40 mg and 80 mg, the company informed the Bombay Stock Exchange.
Advertisement

The company would market the drug through its US subsidiary Zydus Pharmaceuticals (USA) Inc, following patent expiry, it added.

Advertisement
The drug, which had branded sales of approximately 1.8 billion dollars in the US market during 2005, is a lipid lowering agent.

Source:PTI News
Advertisement

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
Notify me when reply is posted I agree to the terms and conditions

You May Also Like

Advertisement
View All

More News on: